Sanofi SA (EPA: SAN)‘s stock had its “buy” rating reaffirmed by analysts at Deutsche Bank in a research report issued to clients and investors on Tuesday, AnalystRatings.Net reports. They currently have a €102.00 ($132.47) price target on the stock.
Shares of Sanofi SA (EPA: SAN) opened at 85.21 on Tuesday. Sanofi SA has a one year low of €53.20 and a one year high of €86.43. The stock’s 50-day moving average is currently €25.25. The company has a market cap of €112.8 billion and a P/E ratio of 27.65.
Other equities research analysts have also recently issued reports about the stock. Analysts at Societe Generale reiterated a “buy” rating on shares of Sanofi SA in a research note to investors on Thursday, May 23rd. They now have a €92.00 ($119.48) price target on the stock. Separately, analysts at BNP Paribas reiterated an “outperform” rating on shares of Sanofi SA in a research note to investors on Tuesday, May 21st. They now have a €95.00 ($123.38) price target on the stock. Finally, analysts at Oddo & Cie reiterated a “buy” rating on shares of Sanofi SA in a research note to investors on Friday, May 17th. They now have a €91.00 ($118.18) price target on the stock.
Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of €71.89 ($93.37).
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.